Stock & Company Details
Acumen Pharmaceuticals Inc $ABOS
Price:
46,691,331
72M
$193M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
0.00
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
ABOS technical indicators
Latest Acumen Pharmaceuticals Inc (ABOS) technical indicators as of 2026-06-30: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
60.59 7.3%
MACD:
0.03 302.8%
SMA 50:
$2.43 0.1%
SMA 200:
$2.27 0.3%
EMA 20:
$2.40 1.2%
Bollinger Bands:
2.63 / 2.04
Stochastic:
76.67 29.2%
ADX 14:
12.59 11.8%
ATR 14:
0.17 0.3%
CCI 20:
271.94 7.9%
OBV:
124.65M 0.5%
ROC 12:
12.66% 46.5%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believe to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody which selectively targets amyloid-beta oligomers.
Finance Bot
Ask your questions
Start by typing a question below.
